OncoTherapy Science Total Liabilities

OncoTherapy Science (4564.T) currently reports a total liabilities of $260M as of June 2026. That compares with $450M in the prior-year period — down 41.2% year over year. Use the charts on this page to explore OncoTherapy Science's total liabilities history and peer comparisons.

OncoTherapy Science's total liabilities decreased from $450M to $260M — a 41.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OncoTherapy Science reported $260M in total liabilities as of June 2026. That compares with $450M in the prior-year period — down 41.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $260M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OncoTherapy Science, and consider following 4564.T for alerts when major investors trade the stock.

OncoTherapy Science is classified in the Healthcare sector. On total liabilities, it currently shows $260M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4564.T with unrelated industries.